85.15
Schlusskurs vom Vortag:
$86.79
Offen:
$84.08
24-Stunden-Volumen:
6.54M
Relative Volume:
3.34
Marktkapitalisierung:
$292.34B
Einnahmen:
$138.28B
Nettoeinkommen (Verlust:
$17.44B
KGV:
18.09
EPS:
4.7081
Netto-Cashflow:
$105.99B
1W Leistung:
-4.64%
1M Leistung:
+4.45%
6M Leistung:
+31.06%
1J Leistung:
+54.29%
Hsbc Holdings Plc Adr Stock (HSBC) Company Profile
Firmenname
Hsbc Holdings Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare HSBC vs JPM, BAC, WFC, RY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HSBC
Hsbc Holdings Plc Adr
|
85.15 | 297.97B | 138.28B | 17.44B | 105.99B | 4.7081 |
|
JPM
Jpmorgan Chase Co
|
302.55 | 815.98B | 279.88B | 56.78B | 45.88B | 20.01 |
|
BAC
Bank Of America Corp
|
52.55 | 378.80B | 194.71B | 30.63B | 42.62B | 3.833 |
|
WFC
Wells Fargo Co
|
86.98 | 266.86B | 123.81B | 21.36B | 35.82B | 6.2626 |
|
RY
Royal Bank Of Canada
|
169.47 | 237.13B | 97.16B | 14.56B | 14.01B | 10.06 |
Hsbc Holdings Plc Adr Stock (HSBC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-14 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-12-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-20 | Hochstufung | Erste Group | Hold → Buy |
| 2025-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-05 | Hochstufung | BNP Paribas Exane | Underperform → Outperform |
| 2025-06-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-03-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-03-27 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-16 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2023-11-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-08-29 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-03 | Hochstufung | Berenberg | Hold → Buy |
| 2023-04-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-05 | Hochstufung | Jefferies | Hold → Buy |
| 2022-10-26 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2022-09-09 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2022-08-17 | Herabstufung | Redburn | Buy → Neutral |
| 2022-08-04 | Herabstufung | Goldman | Buy → Neutral |
| 2022-08-02 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2022-01-27 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2021-12-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-10-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-05 | Hochstufung | UBS | Neutral → Buy |
| 2021-09-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-06-18 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-06-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-03-16 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-02-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-02-09 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2021-01-05 | Herabstufung | Investec | Buy → Hold |
| 2020-11-10 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2020-08-11 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-07-29 | Hochstufung | Investec | Hold → Buy |
| 2020-07-23 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-05-14 | Hochstufung | Berenberg | Sell → Hold |
| 2020-04-01 | Herabstufung | Keefe Bruyette | Outperform → Underperform |
| 2020-03-30 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-03-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-03-06 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2020-02-11 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-02-07 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-11-05 | Herabstufung | Berenberg | Hold → Sell |
| 2019-10-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2019-07-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-06-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2019-02-25 | Herabstufung | Macquarie | Neutral → Underperform |
| 2019-02-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-02-19 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Hsbc Holdings Plc Adr Aktie (HSBC) Neueste Nachrichten
Institutional Custody Services Analysis Report 2026: $43.66 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
HSBC Stock Price, Forecast & Analysis | HSBC HOLDINGS PLC-SPONS ADR (NYSE:HSBC) - ChartMill
HSBC share price today: HSBA stock steadies near 1,301p as BoE decision, results loom - TechStock²
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Morgan Stanley Maintains Equalweight on HSBC Holdings (HSBC), Projects Strong 2025 NII - Finviz
Six dividend ETF picks for RRSP season - The Globe and Mail
Best Foreign and International Stocks: Up to 95% Annual Performance - NerdWallet
82,516 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Bought by Mutual of America Capital Management LLC - MarketBeat
HSBC HOLDINGS Opens 2%+ Higher to Break Ceiling Again w/ Mkt Value Surpassing US$300B for 1st Time - AASTOCKS.com
Manage your shareholding - HSBC
Dynasty Wealth Management LLC Buys New Shares in HSBC Holdings plc $HSBC - Defense World
HSBC share price slips in London as trade jitters weigh on banks, UK inflation in focus - TechStock²
HSBC stock price slips into holiday-shortened week as investors eye Singapore insurance review - TechStock²
HSBC share price ends lower after Singapore insurance review — what to watch before markets reopen - TechStock²
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update - Defense World
Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Short Interest Update - MarketBeat
Looking to ‘Sell America’ Amid Fed Drama? Here’s 1 ETF to Buy. - Barchart.com
Healthcare Venture Markets Regain Momentum as Capital Returns, according to HSBC Innovation Banking - sharewise.com
UK Financial Landscape and FTSE 100 Momentum Around HSBC Holdings - Kalkine Media
HSBC stock week ahead: Hang Seng court date and France tax deal set the tone - TechStock²
Why Smart Money Is Looking Overseas for Bank Stocks - Finviz
The Truth About HSBC Holdings plc: Why Everyone Is Suddenly Watching This Bank Stock - AD HOC NEWS
Reported Privacy Concerns for Early PayMe Users Probed by HK PCPD - AASTOCKS.com
The Truth About HSBC Holdings plc: Is This Banking Giant Actually Worth Your Money? - AD HOC NEWS
HSBC stock today: London shares hit a fresh high as FTSE 100 tops 10,000; U.S. ADRs steady premarket - TechStock²
HSBC Holdings Plc (HSBA) Stock: December 2025 Price, Dividend and 2026 Outlook After BoE Stress Test and Chair Change - ts2.tech
Simplify Asset Management Inc. Purchases Shares of 290,000 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
HSBC Holdings Plc Stock (HSBA, HSBC): Latest December 2025 News, Analyst Forecasts, and the 2026 Catalysts Investors Are Watching - ts2.tech
New Strong Buy Stocks for December 30th - Yahoo Finance
HSBC Holdings Plc Stock in December 2025: New Chair, AI Bet and Capital Relief Shape 2026 Outlook - ts2.tech
Keefe Bruyette Turns More Positive on HSBC, Citing Hong Kong Strength - Finviz
HSBC Holdings plc Positioned Within FTSE 100 Global Banking and Financial Services Sector - Kalkine Media
Finanzdaten der Hsbc Holdings Plc Adr-Aktie (HSBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):